PDF下载 ( 2572 KB)
Analysis of the clinical symptom and its relationship with the clinical classification of hilar cholangiocarcinoma
-
摘要: 目的探讨肝门部胆管癌(HCCA)的早期临床症状及其与临床分型的关系,以期早期诊断。方法采用黄志强建议的在Bismuth分型法基础上的分型方法,根据肿瘤的原发部位分为5型,Ⅰ、Ⅱ型为A组;Ⅲ、Ⅳ、Ⅴ型为B组。对72例病理和临床证实的肝门部胆管癌的主要临床症状、初始症状等临床资料进行分析。结果 72例患者中初始症状表现为无痛性黄疸者仅24例(33.3%);非黄疸者48例(66.7%),主要表现为腹胀并纳差、右上腹部疼痛、尿黄、白陶土样粪便、体重减轻、高热寒战等。A组患者初始症状多表现为无痛性黄疸(53.8%),而B组患者初始症状多表现为非黄疸症状(90.9%)。结论 HACC的临床症状复杂,与病变的临床分型有密切关系。
-
关键词:
- 胆管肿瘤
Abstract: Objective To explore the early clinical symptom and its relationship with the clinical classification for early diagnosis of hilar cholangiocarcinoma (HCCA) .Methods We used the Huang Zhiqiang's typing method based on the Bismuth's method, including five type according to the primary location of tumor.Type Ⅰand Ⅱ was classified as group A and type Ⅲ, Ⅳ and Ⅴ was group B.The main clinical sympotm, primary complaint and other clinical data of 72 HCCA confirmed with pathology and clinical data was analyzed.Results 24 (33.3﹪) HCCA's primary complaint was painless jaundice, and the other 48 (66.7﹪) appeared non-jaundice, including abdominal distention and loss of appetite, right upper abdominal pain, bilirubinuria, porcelain clay stool, body weight loss, hyperpyrexia and algor and so on.The 53.8﹪primary complaint was painless jaundice in group A, and 90.9﹪ was non-jaundice in group B.Conclusion The clinical symptom of HCCA is complicated, and associated deeply with its clinical classification.-
Key words:
- bile duct neoplasms
-
[1]Cormier JN, Vauthey JN.Biliary tract cancer[J].Curr OpinGastroenterology[J].2000, 16 (5) :437-443. [2]石景森, 王炳煌.外科黄疸疾病诊断治疗学[M].北京:人民军医出版社, 2003:381-402. [3]马幼平, 李恩山, 陈孝平, 等.肝门部胆管癌的诊治:附96例报告[J].中国普通外科杂志, 2008, 17 (8) :798-800. [4]DeOliveira ML, Cunningham SC, Cameron JL, et al.Cholangiocarcinoma:thirty-one-year experience with 564patients at a single institution[J].Ann Surg, 2007, 245 (5) :755-762. [5]黄志强.当代胆道外科学[M].上海:上海科学技术出版社, 1998:615-637. [6]郑树国, 何振平, 董家鸿, 等.肝门部胆管癌149例临床分析[J].医学临床研究, 2005, 22 (10) :1369-1371. [7]Clary B, Jarnigan W, Pitt H.Hilar cholangiocarcinoma[J].JGastrointest Surg, 2004, 8 (3) :298-302. [8]Ingrid B, Kelvin H, Richard S, et al.Transcatheter arterialchemoembolization in unresectable cholangiocarcinoma:initial experience in a single institution[J].J Vasc IntervRadiol, 2005, 16 (3) :353-361. [9]张宗利, 柴杰, 马德民, 等.肝门部胆管癌223例临床分析[J].中国现代普通外科进展, 2009, 12 (7) :570-572. [10]Seyama Y, Makuuchi M.Current surgical treatment for bile ductcancer[J].World J Gastroenterol, 2007, 13 (10) :1505-1515. -
本文二维码
计量
- 文章访问数: 3251
- HTML全文浏览量: 19
- PDF下载量: 820
- 被引次数: 0
下载:
